Phase II study of 2-week TS-1 administration followed by 1-week rest for gastric cancer.
Imamura H, Furukawa H, Kishimoto T, Nakae S, Inoue K, Tsukahara Y, Imano M, Yamazaki K, Okano S, Morimoto T, Sugihara S, Shimokawa T.
Imamura H, et al. Among authors: shimokawa t.
Hepatogastroenterology. 2007 Oct-Nov;54(79):2167-71.
Hepatogastroenterology. 2007.
PMID: 18251183
Clinical Trial.